Edition:
United States

Genus PLC (GENS.L)

GENS.L on London Stock Exchange

1,948.00GBp
30 Sep 2016
Change (% chg)

-35.00p (-1.76%)
Prev Close
1,983.00p
Open
1,936.00p
Day's High
1,979.00p
Day's Low
1,936.00p
Volume
36,831
Avg. Vol
72,281
52-wk High
2,056.00p
52-wk Low
1,281.00p

Summary

Name Age Since Current Position

Robert Lawson

71 2010 Non-Executive Independent Chairman of the Board

Karim Bitar

2011 Chief Executive, Executive Director

Stephen Wilson

2013 Group Finance Director, Executive Director

Jonathan Lightner

2013 Chief R&D and Scientific Officer

Dan Hartley

2014 Group General Counsel & Company Secretary

Catherine Glickman

2012 Group Human Resources Director

Bill Christianson

2013 Chief Operating Officer - Genus PIC

Saskia Romani

2014 Chief Operating Officer - Genus ABS

Jerry Thompson

2012 Chief Operating Officer, Genus Asia

Lykele Broek

2014 Non-Executive Director

Lysanne Gray

2016 Non-Executive Director

Duncan Maskell

2014 Non-Executive Director

Mike Buzzacott

2009 Non-Executive Independent Director

Nigel Turner

2008 Senior Non-Executive Independent Director

Biographies

Name Description

Robert Lawson

Mr. Robert A. Lawson, (Bob) is Non-Executive Independent Chairman of the Board of Genus PLC. Bob’s executive career spanned several UK and continental groups, including ten years as Chief Executive of Electrocomponents plc and three years as Managing Director of Vitec Group plc. He has experience of leading international businesses, including through operational and culture changes, and a deep understanding of listed companies and corporate governance. He was appointed Non-Executive Chairman of Eurocell plc in January 2015 and is Chairman of the Federation of Groundwork Trusts. Bob retired as Non-Executive Chairman of Barratt Developments plc in November 2014.

Karim Bitar

Mr. Karim Bitar serves as Chief Executive, Executive Director of Genus PLC. Prior to joining Genus, Karim worked for more than 15 years for Eli Lilly and Company, where he was President of Lilly Europe, Canada and Australia. An ex-McKinsey and Company consultant, he also held management roles at Johnson and Johnson, and the Dow Chemical Company. Karim has extensive experience of leading international, science-based organisations. His strategic review of Genus in 2012 resulted in a new vision, strategy, structure and core values. He has a BSc in Biochemistry from the University of Wisconsin and an MBA from the University of Michigan.

Stephen Wilson

Mr. Stephen Wilson serves as Group Finance Director, Executive Director of Genus PLC. He was previously Executive Vice President and Chief Financial Officer of Misys plc. Prior to Misys, he spent 25 years at IBM, where he worked in all areas of finance and led business development and change programmes. Stephen has worked in France and the US and has wideranging experience of mergers and acquisitions, financing, strategy and investor relations. He is a Fellow of the Chartered Institute of Management Accountants and a Non-Executive Director of Xchanging plc, where he chairs the Audit Committee. He holds a degree in Mathematics from the University of Cambridge.

Jonathan Lightner

Dr. Jonathan Lightner is Chief R&D and Scientific Officer of Genus PLC. He is a world-renowned quantitative molecular geneticist, whose career has encompassed R&D, regulatory and commercial activities. He joined us in 2013 from Pioneer Hi-bred International Inc, a DuPont business, where he led a global team focused on genetic solutions to enhance agricultural productivity. He has been issued over 40 patents in key areas related to crop improvement. He obtained his Doctorate in Plant Physiology at the Institute of Biological Chemistry at Washington State University in 1994. He also holds a Masters in Systems Engineering from Iowa State (2009) and an MBA from the University of Iowa (2009).

Dan Hartley

Mr. Dan Hartley is Group General Counsel & Company Secretary of Genus PLC. He joined Genus from Shire plc, where he was Senior Vice President and International Counsel. An Australian and UK dual national, Dan holds degrees in science and law. After a number of years in private practice, Dan joined Shire in 2002 and worked in increasingly senior and global roles in the UK and US. He has significant experience in multi-jurisdictional patent litigation, mergers and acquisitions, patent licensing and managing product life cycles in complex areas.

Catherine Glickman

Ms. Catherine Janet Glickman has been Group Human Resources Director of Genus Plc. She joined Genus in 2012. She worked for Tesco plc for 20 years, where she was Group HR Director from 2008 to 2011, focusing on talent, succession and leadership development. She held HR Director roles supporting Tesco’s international roll-out and a period of major expansion for the UK stores. She sat on both the Health and Safety, and CSR Committees and was a pension trustee. Prior to Tesco, she worked in HR for Somerfield plc and Boots plc. Catherine holds a degree in English Language and Literature from Durham University and is a member of the Institute of Personnel and Development.

Bill Christianson

Mr. Bill Christianson serves as Chief Operating Officer - Genus PIC of Genus PLC. He joined Genus in 1993 in research, then moved into operations across Europe. He returned to the US in 1998, taking on increasingly senior roles. He was appointed General Manager of PIC North America in 2007 and from 2010 led the combined PIC and ABS businesses across the Americas. He became PIC’s Chief Operating Officer in 2012. Bill has a unique combination of deep domain knowledge of the porcine industry and extensive commercial and global experience. He has doctorates (DVM and PhD) in Veterinary Medicine from the University of Minnesota.

Saskia Romani

Ms. Saskia Korink Romani is Chief Operating Officer - Genus ABS of Genus PLC. She became Chief Operating Officer of Genus ABS in January 2014, having joined Genus in 2013 as Chief Marketing Officer. Prior to Genus, she worked for Cargill Inc and was its first female business unit manager and ultimately Vice President of Marketing for its animal nutrition business. Saskia has wide international experience, having worked in Europe, Brazil and the US. She also has highly developed strategic and business development skills, from seven years with Boston Consulting Group. Multi-lingual, she is originally a physicist and has an MBA from Columbia Business School.

Jerry Thompson

Mr. Jerry Thompson is Chief Operating Officer, Genus Asia of Genus PLC. He has worked for PIC and subsequently Genus for more than 20 years. After two years on the graduate programme in the UK, he took roles in Siberia and Romania, before being promoted to head up PIC in Central and Eastern Europe. In 2008, Jerry was appointed Regional Director for PIC Europe. He moved to Shanghai in 2010, as Regional Director for PIC and ABS in Russia and the Asia Pacific Region. In July 2012, he was promoted onto GELT as Chief Operating Officer for Asia. Jerry is a natural entrepreneur and has a deep operational knowledge of the PIC business and emerging markets.

Lykele Broek

Mr. Lykele van der Broek is Non-Executive Director of Genus PLC. Lykele van der Broek. He joined the Board in July 2014. He retired as a member of the Executive Committee of Bayer CropScience, a division of Bayer AG, on 31 July 2014. Prior to this he held senior international roles, including Head of the Bayer CropScience BioScience division and President of the Bayer HealthCare Animal Health division. He has a Master of Science degree from the Agricultural University in Wageningen, the Netherlands. Lykele has vast experience of growing companies and of working in agricultural businesses in Asia, Europe and Latin America.

Lysanne Gray

Ms. Lysanne Gray is appointed as Non-Executive Director of the Company, effective 1 April 2016. Lysanne, a chartered accountant with a chemistry degree from Southampton University, is the Financial Controller at Unilever plc. Prior to this, she was Chief Auditor working closely with Unilever's Audit Committee and before that Chief Financial Officer of Unilever's global food service business. She has also held a number of other senior management positions within Unilever, both operational and financial and has had significant acquisition/disposal experience.

Duncan Maskell

Prof. Duncan Maskell is Non-Executive Director of Genus PLC. Duncan Maskell joined the Board in April 2014. He is Senior Pro-Vice Chancellor (‘PVC’) of the University of Cambridge, where he and other PVCs are responsible for taking forward the University’s strategy and policy development. He was previously Head of the School of the Biological Sciences at the University where he led researchers working on infectious diseases of livestock and people. He has worked on vaccines at Wellcome Biotech and on bacteria that cause childhood meningitis at the Institute of Molecular Medicine, University of Oxford. Duncan has been instrumental in co-founding several biotech companies. He has extensive experience of commercialising science and innovation, and of being a scientific adviser to companies, using his broad perspective on life sciences.

Mike Buzzacott

Mr. Mike Buzzacott is no longer as Non-Executive Independent Director of Genus PLC, effective November 2016. He is a Non-Executive Director of Scapa Plc. He is a qualified accountant and spent 34 years at BP, holding international roles including Finance and Control Director Asia Pacific, CFO BP Nutrition and Group Vice President Petrochemicals. He is a former Non-Executive Director of Croda plc and Rexam plc and was Chairman of Biofuels plc. His roles have given him extensive experience of working in Asian and European markets, and of dealing with acquisitions, mergers and divestments.

Nigel Turner

Mr. Nigel Turner serves as Senior Non-Executive Independent Director of Genus PLC. He is a Non-Executive Director of Croda plc. He was Chairman of Numis Securities Ltd and Deputy Chairman of Numis Corporation plc from December 2005 to November 2007. Previously he was Vice Chairman of ABN AMRO’s Wholesale and Investment Bank, having joined in 2000 from Lazard, where he was a Partner for 15 years and also sat on its Supervisory Board. Nigel has substantial experience of international business and corporate finance.